PE20010044A1 - Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona - Google Patents

Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona

Info

Publication number
PE20010044A1
PE20010044A1 PE2000000365A PE0003652000A PE20010044A1 PE 20010044 A1 PE20010044 A1 PE 20010044A1 PE 2000000365 A PE2000000365 A PE 2000000365A PE 0003652000 A PE0003652000 A PE 0003652000A PE 20010044 A1 PE20010044 A1 PE 20010044A1
Authority
PE
Peru
Prior art keywords
polymorph
diona
pyridyl
ethoxy
benzyl
Prior art date
Application number
PE2000000365A
Other languages
English (en)
Inventor
Robert Gordon Giles
Timothy G Coakley
Gillian Morrissey
Christine Marie Browne
Paul David James Blackler
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Cork Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315461&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20010044(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909473.2A external-priority patent/GB9909473D0/en
Priority claimed from GBGB9912196.4A external-priority patent/GB9912196D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham Cork Ltd filed Critical Smithkline Beecham Plc
Publication of PE20010044A1 publication Critical patent/PE20010044A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

SE REFIERE A UNA FORMA POLIMORFICA DE LA SAL DEL ACIDO MALEICO DE 5-[4-[2-(N-METIL-N-(2-PIRIDIL)AMINO)ETOXI]BENCIL]-TIAZOLIDINA-2,4-DIONA AISLADO EN FORMA PURA, CRISTALINA CARACTERIZADO POR SUS PROPIEDADES FISICAS: ESPECTRO INFRARROJO, ESPECTRO RAMAN, ESPECTRO DE RESONANCIA MAGNETICA NUCLEAR, PATRON DE DIFRACCION DE RAYOS X. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION QUE COMPRENDE: a) EL COMPUESTO SE SUSPENDE EN ACETONA Y SE AGITA A UNA TEMPERATURA ELEVADA DURANTE UN PERIODO DE TIEMPO PROLONGADO; b) SE SIEMBRA EL COMPUESTO EN ETANOL DESNATURALIZADO A UNA TEMPERATURA ELEVADA CON CRISTALES DEL POLIMORFO, ENTONCES SE ENFRIA LA MEZCLA DE REACCION PARA PROPORCIONAR EL POLIMORFO, DESPUES DE LO CUAL SE RECUPERA EL POLIMORFO DEL ETANOL DESNATURALIZADO. EL POLIMORFO DE LA SAL DEL ACIDO MALEICO DE 5-[4-[2-(N-METIL-N-(2-PIRIDIL)AMINO)ETOXI]BENCIL]-TIAZOLIDINA-2,4-DIONA ES UTIL PARA EL TRATAMIENTO DE DIABETES MELLITUS Y SUS COMPLICACIONES
PE2000000365A 1999-04-23 2000-04-19 Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona PE20010044A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909473.2A GB9909473D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912196.4A GB9912196D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
PE20010044A1 true PE20010044A1 (es) 2001-03-10

Family

ID=26315461

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000365A PE20010044A1 (es) 1999-04-23 2000-04-19 Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona

Country Status (40)

Country Link
US (2) US6806280B1 (es)
EP (2) EP1304330A3 (es)
JP (1) JP2002543077A (es)
KR (1) KR100744360B1 (es)
CN (1) CN1167702C (es)
AP (1) AP1598A (es)
AR (2) AR023561A1 (es)
AT (1) ATE246191T1 (es)
AU (1) AU765005B2 (es)
BG (1) BG65485B1 (es)
BR (1) BR0009932A (es)
CA (1) CA2370280A1 (es)
CO (1) CO5170421A1 (es)
CZ (1) CZ20013800A3 (es)
DE (1) DE60004196T2 (es)
DK (1) DK1173435T3 (es)
DZ (1) DZ3156A1 (es)
EA (1) EA004541B1 (es)
ES (1) ES2203453T3 (es)
HK (1) HK1045153B (es)
HR (1) HRP20010772B1 (es)
HU (1) HUP0200931A3 (es)
IL (1) IL146111A0 (es)
MA (1) MA25356A1 (es)
MX (1) MXPA01010821A (es)
MY (1) MY131973A (es)
NO (1) NO320574B1 (es)
NZ (1) NZ515168A (es)
OA (1) OA11872A (es)
PE (1) PE20010044A1 (es)
PL (1) PL351684A1 (es)
PT (1) PT1173435E (es)
SK (1) SK286427B6 (es)
TR (1) TR200103062T2 (es)
TW (1) TWI283677B (es)
UA (1) UA67844C2 (es)
UY (1) UY26121A1 (es)
WO (1) WO2000064896A1 (es)
YU (1) YU75301A (es)
ZA (1) ZA200108719B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
BR0114196A (pt) * 2000-09-26 2003-07-22 Reddy S Res Foundation Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
KR100673140B1 (ko) * 2002-04-19 2007-01-22 파에스 파마, 에스.에이. 4-[2-[4-[1-(2-에톡시에틸)-1Ｈ-벤즈이미다졸-2-일] -1-피페리디닐]에틸]- α,α-디메틸- 벤젠아세틱 애시드의 동질이상체
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (en) * 2004-01-28 2006-10-11 Usv Limited A process for the preparation of 5- 4- 2- n-methyl -n-(2-pyridyl) amino ethoxy phenyl methyl thiaz olidine-2, 4-dione maleate
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Ｊａｋ激酶家族之小分子抑制劑

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US6462337B1 (en) * 2000-04-20 2002-10-08 Agilent Technologies, Inc. Mass spectrometer electrospray ionization
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
US6632947B2 (en) * 1997-02-18 2003-10-14 Smithkline Beecham Plc Process for the preparation of substituted thiazolidinedione
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US7091359B2 (en) * 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US6613785B2 (en) * 1998-07-21 2003-09-02 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
EP1175418A2 (en) 1999-04-23 2002-01-30 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CN1277965A (zh) 2000-06-14 2000-12-27 中国医药研究开发中心 盐酸罗格列酮及其应用
BR0114196A (pt) 2000-09-26 2003-07-22 Reddy S Res Foundation Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.

Also Published As

Publication number Publication date
YU75301A (sh) 2004-07-15
KR100744360B1 (ko) 2007-07-30
MA25356A1 (fr) 2001-12-31
CZ20013800A3 (cs) 2002-04-17
BG106121A (en) 2002-05-31
NO20015147L (no) 2001-12-17
EP1173435B1 (en) 2003-07-30
OA11872A (en) 2006-03-27
HK1045153A1 (en) 2002-11-15
HRP20010772A2 (en) 2002-10-31
US20050080114A1 (en) 2005-04-14
IL146111A0 (en) 2002-07-25
UY26121A1 (es) 2000-12-29
CN1167702C (zh) 2004-09-22
CO5170421A1 (es) 2002-06-27
SK286427B6 (sk) 2008-09-05
EP1173435A1 (en) 2002-01-23
CN1356999A (zh) 2002-07-03
ES2203453T3 (es) 2004-04-16
AU765005B2 (en) 2003-09-04
MXPA01010821A (es) 2003-09-04
NO20015147D0 (no) 2001-10-22
WO2000064896A9 (en) 2001-10-25
US6806280B1 (en) 2004-10-19
TR200103062T2 (tr) 2002-05-21
UA67844C2 (uk) 2004-07-15
HK1045153B (zh) 2004-07-09
WO2000064896A1 (en) 2000-11-02
MY131973A (en) 2007-09-28
PL351684A1 (en) 2003-06-02
AU4130800A (en) 2000-11-10
NZ515168A (en) 2004-02-27
BR0009932A (pt) 2002-04-09
HRP20010772B1 (en) 2007-05-31
AP1598A (en) 2006-04-26
EA200101121A1 (ru) 2002-04-25
TWI283677B (en) 2007-07-11
AR023565A1 (es) 2002-09-04
HUP0200931A3 (en) 2004-03-29
DE60004196D1 (de) 2003-09-04
DK1173435T3 (da) 2003-11-24
KR20010110797A (ko) 2001-12-13
AP2001002330A0 (en) 2000-12-31
JP2002543077A (ja) 2002-12-17
EP1304330A2 (en) 2003-04-23
AR023561A1 (es) 2002-09-04
HUP0200931A2 (en) 2002-08-28
DE60004196T2 (de) 2004-04-15
CA2370280A1 (en) 2000-11-02
SK14922001A3 (sk) 2002-02-05
PT1173435E (pt) 2003-12-31
EP1304330A3 (en) 2003-11-19
EA004541B1 (ru) 2004-06-24
ZA200108719B (en) 2002-06-21
ATE246191T1 (de) 2003-08-15
NO320574B1 (no) 2005-12-27
BG65485B1 (bg) 2008-09-30
DZ3156A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
PE20010044A1 (es) Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
PE20010040A1 (es) Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
KR102187608B1 (ko) Ssao 억제제
ES2314460T3 (es) Compuestos de 2,3-dihidro-6-nitroimidazo (2,1-b)oxazol para el tratamiento de la tuberculosis.
ES2657121T3 (es) Derivados de diazacarbazol como ligandos tau-pet
OA11567A (en) Polymorphic clopidogrel hydrogenesulphate form.
JP5167123B2 (ja) ドーパミンｄ３受容体モジュレーターとしてのアザビシクロ［３．１．０］ヘキサン誘導体
WO2020085504A1 (ja) 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
PE20000125A1 (es) Hidrato de la sal de acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona
UA78291C2 (en) N-aminoacetylpyrrolidine-2-carbonitrils, method for production thereof, pharmaceutical composition, application thereof, and intermediate products for production process
Yar et al. Synthesis and Anti Tuberculostatic Activity of Novel 1, 3, 4‐Oxadiazole Derivatives
TW200817406A (en) Imidazole amines as inhibitors of β-secretase
WO2015192701A1 (zh) 氨基吡喃环衍生物及其组合物和应用
PE20010045A1 (es) Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona
US20120322827A1 (en) Compounds and methods
US20150353577A1 (en) Method for producing (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one
JP2005516011A (ja) 結晶二水化セフニディールカリウム
CA2975157C (en) Sulfonamide-substituted indole modulators of rorc2 and methods of use thereof
JP3306473B1 (ja) β−ラクタム化合物の無水結晶及びその製造法
CN111635373B (zh) 多环磺酰胺类RORγ调节剂
WO2010098496A1 (en) Process for producing tetrahydrotriazolopyridine derivative
ES2253315T3 (es) Analogos de fenoxacina para el tratamiento de amiloides.
US9233984B2 (en) Compound, method for producing compound, and method for purifying compound
TW202019872A (zh) 稠合三環γ-胺基酸衍生物的製備方法及其中間體
US2483137A (en) Synthesis of vitamin b6

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed